These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17510061)

  • 1. Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions.
    Al-Ayyoubi M; Schwartz BS; Gettins PG
    J Biol Chem; 2007 Jul; 282(27):19502-9. PubMed ID: 17510061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of Michaelis complex, acylation, and conformational change steps in the reactions of the serpin, plasminogen activator inhibitor-1, with tissue plasminogen activator and trypsin.
    Olson ST; Swanson R; Day D; Verhamme I; Kvassman J; Shore JD
    Biochemistry; 2001 Oct; 40(39):11742-56. PubMed ID: 11570875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin.
    McGowen R; Biliran H; Sager R; Sheng S
    Cancer Res; 2000 Sep; 60(17):4771-8. PubMed ID: 10987285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of the exosite residues of plasminogen activator inhibitor-1 to proteinase inhibition.
    Ibarra CA; Blouse GE; Christian TD; Shore JD
    J Biol Chem; 2004 Jan; 279(5):3643-50. PubMed ID: 14594804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
    Egelund R; Petersen TE; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin.
    Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW
    Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.
    Sheng S; Truong B; Fredrickson D; Wu R; Pardee AB; Sager R
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):499-504. PubMed ID: 9435220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.
    Yin S; Lockett J; Meng Y; Biliran H; Blouse GE; Li X; Reddy N; Zhao Z; Lin X; Anagli J; Cher ML; Sheng S
    Cancer Res; 2006 Apr; 66(8):4173-81. PubMed ID: 16618739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop.
    Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB
    Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.
    Warejcka DJ; Narayan M; Twining SS
    Exp Eye Res; 2011 Nov; 93(5):618-27. PubMed ID: 21810423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin inhibits cell migration in the absence of protease inhibitory activity.
    Bass R; Fernández AM; Ellis V
    J Biol Chem; 2002 Dec; 277(49):46845-8. PubMed ID: 12384513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of complex formation between plasminogen activator inhibitor-1 and its target proteinases.
    Aertgeerts K; De Ranter CJ; Booth NA; Declerck PJ
    J Struct Biol; 1997 Apr; 118(3):236-42. PubMed ID: 9169233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin.
    Biliran H; Sheng S
    Cancer Res; 2001 Dec; 61(24):8676-82. PubMed ID: 11751384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion of the catalytic domain of tissue-type plasminogen activator by plasminogen activator inhibitor-1 coincides with the formation of stable serpin-proteinase complexes.
    Perron MJ; Blouse GE; Shore JD
    J Biol Chem; 2003 Nov; 278(48):48197-203. PubMed ID: 14500731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protonation state of a single histidine residue contributes significantly to the kinetics of the reaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator.
    Komissarov AA; Declerck PJ; Shore JD
    J Biol Chem; 2004 May; 279(22):23007-13. PubMed ID: 15033993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory mechanism of serpins: loop insertion forces acylation of plasminogen activator by plasminogen activator inhibitor-1.
    Kvassman JO; Verhamme I; Shore JD
    Biochemistry; 1998 Nov; 37(44):15491-502. PubMed ID: 9799512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
    Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role of novel serpin maspin in tumor progression: the divergence revealed through efforts to converge.
    Sheng S
    J Cell Physiol; 2006 Dec; 209(3):631-5. PubMed ID: 17001674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism.
    Shore JD; Day DE; Francis-Chmura AM; Verhamme I; Kvassman J; Lawrence DA; Ginsburg D
    J Biol Chem; 1995 Mar; 270(10):5395-8. PubMed ID: 7890653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization.
    Egelund R; Einholm AP; Pedersen KE; Nielsen RW; Christensen A; Deinum J; Andreasen PA
    J Biol Chem; 2001 Apr; 276(16):13077-86. PubMed ID: 11278457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.